湖北师范学院学报:自然科学版
湖北師範學院學報:自然科學版
호북사범학원학보:자연과학판
Journal of Hubei Normal University(Natural Science)
2012年
3期
30-32,49
,共4页
卡马西平%尿毒症%周围神经病变%感觉神经传导速度
卡馬西平%尿毒癥%週圍神經病變%感覺神經傳導速度
잡마서평%뇨독증%주위신경병변%감각신경전도속도
carbamazepine%uremia%uremic peripheral nervous lesion%sensory conduction velocity
探讨卡马西平对尿毒症性周围神经病变的治疗作用。选择45例确诊尿毒症性周围神经病变的维持性血液透析尿毒症患者,随机分为治疗组(n=23)和对照组(n=22),分别给予卡马西平(100mg,每日3次)和安慰剂治疗8周;两组患者均每周行3次常规血液透析治疗。治疗前、治疗4周、治疗8周时分别观察两组患者周围神经病变的临床症状及正中神经、胫神经、腓总神经的感觉神经传导速度(SCV).治疗8周后,对照组患者周围神经病变的临床症状及感觉神经传导速度无明显改善。而治疗组患者周围神经病变的临床症状及感觉神经传导速度较治疗前有明显改善,其程度显著优于对照组(P〈0.05).卡马西平能有效地改善尿毒症性周围神经病变。
探討卡馬西平對尿毒癥性週圍神經病變的治療作用。選擇45例確診尿毒癥性週圍神經病變的維持性血液透析尿毒癥患者,隨機分為治療組(n=23)和對照組(n=22),分彆給予卡馬西平(100mg,每日3次)和安慰劑治療8週;兩組患者均每週行3次常規血液透析治療。治療前、治療4週、治療8週時分彆觀察兩組患者週圍神經病變的臨床癥狀及正中神經、脛神經、腓總神經的感覺神經傳導速度(SCV).治療8週後,對照組患者週圍神經病變的臨床癥狀及感覺神經傳導速度無明顯改善。而治療組患者週圍神經病變的臨床癥狀及感覺神經傳導速度較治療前有明顯改善,其程度顯著優于對照組(P〈0.05).卡馬西平能有效地改善尿毒癥性週圍神經病變。
탐토잡마서평대뇨독증성주위신경병변적치료작용。선택45례학진뇨독증성주위신경병변적유지성혈액투석뇨독증환자,수궤분위치료조(n=23)화대조조(n=22),분별급여잡마서평(100mg,매일3차)화안위제치료8주;량조환자균매주행3차상규혈액투석치료。치료전、치료4주、치료8주시분별관찰량조환자주위신경병변적림상증상급정중신경、경신경、비총신경적감각신경전도속도(SCV).치료8주후,대조조환자주위신경병변적림상증상급감각신경전도속도무명현개선。이치료조환자주위신경병변적림상증상급감각신경전도속도교치료전유명현개선,기정도현저우우대조조(P〈0.05).잡마서평능유효지개선뇨독증성주위신경병변。
Objective To evaluate the effect of carbamazepine in treatment of uremic peripheral nervous lesion.Methods Forty-five patients with uremic peripheral nervous lesion were selected and randomly divided into therapy group(n=23) and control group(n=22),receive respectively carbamazepine(100mg three times a day) and placebo treatment for eight weeks.All patients received regular hemodialysis thrice a week.The clinical symptoms and the sensory conduction velocity(SCV) of median nerve,tibial nerve and lateral popliteal nerve were measured in each group before,four weeks and eight weeks cost treatment respectively.Results After eight weeks treatment,the clinical symptoms,the nerve reflex and the SCV showed no obviously difference in control group,but significantly improvement in therapy group(P0.05).Conclusion Carbamazepine are effective for patients with uremic peripheral nervous lesion.